Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Endometrial Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
2 Recruiting STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy;   Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
3 Recruiting The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Procedure: TH;   Procedure: TH/BSO;   Procedure: BPLND
4 Recruiting Genetic Pap Test for Endometrial and Ovarian Cancers
Conditions: Ovarian Neoplasms;   Endometrial Neoplasms
Intervention:
5 Recruiting The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Drug: Paclitaxel;   Drug: Paraplatin (Carboplatin Injection);   Radiation: Pelvic Radiation;   Radiation: Vaginal Brachytherapy 1;   Radiation: Vaginal brachytherapy 2
6 Unknown  Early Detection of Cancers in Low Resource Countries
Conditions: Breast Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Endometrial Neoplasms
Interventions: Procedure: Breast Cancer Screening and Diagnosis;   Procedure: Cervical Cancer Screening and Diagnosis;   Procedure: Ovarian Cancer Screening and Diagnosis;   Procedure: Endometrial Cancer Screening and Diagnosis
7 Unknown  Questionnaire Study for Gynecological Cancer Survivors
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms;   Uterine Cervical Neoplasms;   Vulvar Neoplasms;   Vaginal Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: Psychosocial
8 Not yet recruiting Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma
Condition: Endometrial Neoplasms
Intervention: Drug: Ponatinib
9 Recruiting [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Conditions: Uterine Cervical Neoplasms;   Endometrial Neoplasms;   Anus Neoplasms;   Rectal Neoplasms;   Prostatic Neoplasms
Intervention: Radiation: Bone marrow sparing IMRT radiation therapy
10 Recruiting Robotic Versus Abdominal Surgery for Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Procedure: Robotic surgery;   Procedure: Abdominal surgery
11 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
12 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
13 Not yet recruiting Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: Recurrent Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Intervention: Other: laboratory biomarker analysis
14 Unknown  Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia
Condition: Endometrial Carcinoma
Intervention:
15 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
16 Recruiting Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma
Condition: Endometrial Carcinoma
Intervention: Dietary Supplement: Curcuphyt
17 Recruiting Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
18 Unknown  Letrozole as a Treatment of Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: Letrozole
19 Recruiting Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Conditions: Adrenocortical Adenoma;   Sarcoma, Endometrial Stromal
Interventions: Procedure: MRI;   Procedure: Dexamethasone Supression Test;   Procedure: Sonogram;   Procedure: Biopsy;   Drug: BGG492
20 Not yet recruiting Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   High Grade Ovarian Serous Adenocarcinoma;   Ovarian Endometrioid Tumor;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: Olaparib;   Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years